Valneva's Covid-19 vaccine contract with Europe collapses to just a fraction of the original deal
The European Commission on Wednesday announced that it would only purchase 1.25 million doses of Valneva’s newly authorized Covid-19 vaccine, after originally purchasing 60 million doses.
The EC first sent a notice of intent to terminate the purchase agreement back in May, as the regulatory review of Valneva’s vaccine stalled. In late June, the European Medicines Agency recommended Valneva’s shot for the primary vaccination of adults, but the company warned that its supply deal might be dead in the water.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.